Page last updated: 2024-08-24

lercanidipine and Cardiac Hypertrophy

lercanidipine has been researched along with Cardiac Hypertrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Y; Jiang, G; Lv, Q; Yuan, J; Zhu, J; Zou, Y	1

Other Studies

1 other study(ies) available for lercanidipine and Cardiac Hypertrophy

Article	Year
Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling. Molecular medicine reports, 2017, Volume: 16, Issue:4 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcineurin; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cells, Cultured; Dihydropyridines; Gene Expression Regulation; Histone Deacetylases; Myocytes, Cardiac; Natriuretic Peptide, Brain; NFATC Transcription Factors; Rats; Signal Transduction	2017

Article

Year

Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling.

Molecular medicine reports, 2017, Volume: 16, Issue:4

Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcineurin; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cells, Cultured; Dihydropyridines; Gene Expression Regulation; Histone Deacetylases; Myocytes, Cardiac; Natriuretic Peptide, Brain; NFATC Transcription Factors; Rats; Signal Transduction

2017